Ube2v1 interacts with Ubc13 through non-covalent binding to mediate formation of K63-linked polyubiquitin chains (K63Ub chains), which activate the NF-κB pathway to regulate inflammation and cancer occurrence (6,16,18). Here, UBE2V1 is linked to cancer.